The Evolution of AIFA Registries to Support Managed Entry Agreements for Orphan Medicinal Products in Italy

Italy has a well-established prominent system of national registries to support managed entry agreements (MEAs), monitoring innovative medicinal products (MPs) with clinical as well as economic uncertainties to ensure appropriate use and best value for money. The technological architecture of the re...

Descripción completa

Detalles Bibliográficos
Autores principales: Xoxi, Entela, Facey, Karen M, Cicchetti, Americo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386173/
https://www.ncbi.nlm.nih.gov/pubmed/34456724
http://dx.doi.org/10.3389/fphar.2021.699466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386173/
https://www.ncbi.nlm.nih.gov/pubmed/34456724
http://dx.doi.org/10.3389/fphar.2021.699466

Ejemplares similares